Depression Care360

In this video, Greg Mattingly, MD, discusses nonpharmacological strategies that patients can use to help reduce depressive symptoms.

A group of new, fast-acting antidepressants has a different mechanism of action than traditional antidepressants.

Research has shown chronic depression decreases the size of the hippocampus and damages parts of the anterior cingulate and other pathways in the brain.

In this video, Greg Mattingly, MD, Associate Clinical Professor, Washington University, St. Louis, Missouri, talks about the neurological impacts of chronic depression.

Greg Mattingly, MD, Associate Clinical Professor, Washington University, St. Louis, Missouri, discusses needs that remain unmet in the treatment of depression.

In this video, W. Clay Jackson, MD, DipTh, discusses the management of depression in primary care, a topic he is speaking about at our Practical Updates in Primary Care 2020 Virtual Series on October...

In this video, researcher and neuropsychiatrist Reza Hosseini Ghomi, MD, MSE, shares details about a study that suggests automatic language processing may be able to play a role in detecting and...

Michael Thase, MD, of the University of Pennsylvania explains the risks of using antipsychotics in the treatment of depression.

Michael Thase, MD, weighs in on when lithium should be considered as a depression treatment and when it should it be avoided.

Michael Genovese, MD, JD, chief medical advisor of Acadia Healthcare's Recovery Division, explains how performing a DNA analysis could help physicians select treatment options for depression that are right...